CTLA4 and neoplasm: Notably, dual checkpoint blockade was achieved by co-delivering PD-L1 and CTLA-4 small interfering RNAs (siRNAs) via exosomes, thereby repressing malignant features of CRC cells, restraining tumor growth, and activating tumor immune responses [14].